Innoviva, Inc. (INVA)
NASDAQ: INVA · Real-Time Price · USD
21.42
-0.47 (-2.15%)
May 29, 2026, 4:00 PM EDT - Market closed

Innoviva Revenue

Innoviva had revenue of $97.99M in the quarter ending March 31, 2026, with 10.56% growth. This brings the company's revenue in the last twelve months to $420.69M, up 13.75% year-over-year. In the year 2025, Innoviva had annual revenue of $411.33M with 14.67% growth.

Revenue (ttm)
$420.69M
Revenue Growth
+13.75%
P/S Ratio
3.76
Revenue / Employee
$2,645,849
Employees
159
Market Cap
1.58B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025411.33M52.62M14.67%
Dec 31, 2024358.71M48.25M15.54%
Dec 31, 2023310.46M-20.88M-6.30%
Dec 31, 2022331.34M-60.53M-15.45%
Dec 31, 2021391.87M55.07M16.35%
Dec 31, 2020336.79M75.78M29.03%
Dec 31, 2019261.02M12.00K-
Dec 31, 2018261.00M43.79M20.16%
Dec 31, 2017217.22M83.65M62.63%
Dec 31, 2016133.57M79.62M147.58%
Dec 31, 201553.95M45.52M539.74%
Dec 31, 20148.43M3.90M86.08%
Dec 31, 20134.53M-1.08M-19.26%
Dec 31, 20125.61M-18.90M-77.10%
Dec 31, 201124.51M289.00K1.19%
Dec 31, 201024.22M-151.00K-0.62%
Dec 31, 200924.37M1.28M5.53%
Dec 31, 200823.10M1.09M4.97%
Dec 31, 200722.00M2.42M12.33%
Dec 31, 200619.59M7.53M62.49%
Dec 31, 200512.05M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Ardelyx427.68M
AnaptysBio232.39M
Nuvation Bio143.05M
Vir Biotechnology65.50M
Immatics43.00M
Precigen31.60M
AtaiBeckley3.49M
Inhibrx Biosciences1.30M
Revenue Rankings